| 1 | ag results an agresults | | | | | | | 1 | 0.65% |
| 2 | world picture3 have | | | | | | | 1 | 0.65% |
| 3 | to the official competition | | | | | | | 1 | 0.65% |
| 4 | the official competition rules | | | | | | | 1 | 0.65% |
| 5 | pharmaceutical companies and other | | | | | | | 1 | 0.65% |
| 6 | and pharmaceutical companies and | | | | | | | 1 | 0.65% |
| 7 | biotech and pharmaceutical companies | | | | | | | 1 | 0.65% |
| 8 | health biotech and pharmaceutical | | | | | | | 1 | 0.65% |
| 9 | animal health biotech and | | | | | | | 1 | 0.65% |
| 10 | official competition rules the | | | | | | | 1 | 0.65% |
| 11 | results an agresults initiative | | | | | | | 1 | 0.65% |
| 12 | picture3 have a winning | | | | | | | 1 | 0.65% |
| 13 | picture3 have a | | | | | | | 1 | 0.65% |
| 14 | developing world picture3 | | | | | | | 1 | 0.65% |
| 15 | organizations are invited to | | | | | | | 1 | 0.65% |
| 16 | the developing world | | | | | | | 1 | 0.65% |
| 17 | across the developing world | | | | | | | 1 | 0.65% |
| 18 | ruminants across the developing | | | | | | | 1 | 0.65% |
| 19 | small ruminants across the | | | | | | | 1 | 0.65% |
| 20 | agresults initiative is a | | | | | | | 1 | 0.65% |
| 21 | initiative is a partnership | | | | | | | 1 | 0.65% |
| 22 | against brucella melitensis in | | | | | | | 1 | 0.65% |
| 23 | use against brucella melitensis | | | | | | | 1 | 0.65% |
| 24 | for use against brucella | | | | | | | 1 | 0.65% |
| 25 | viable for use against | | | | | | | 1 | 0.65% |
| 26 | document all prizes and | | | | | | | 1 | 0.65% |
| 27 | subject to the official | | | | | | | 1 | 0.65% |
| 28 | are invited to submit | | | | | | | 1 | 0.65% |
| 29 | efficacious safe and viable | | | | | | | 1 | 0.65% |
| 30 | all requirements regarding the | | | | | | | 1 | 0.65% |
| 31 | all prizes and all | | | | | | | 1 | 0.65% |
| 32 | prizes and all requirements | | | | | | | 1 | 0.65% |
| 33 | and all requirements regarding | | | | | | | 1 | 0.65% |
| 34 | is not an official | | | | | | | 1 | 0.65% |
| 35 | this is not an | | | | | | | 1 | 0.65% |
| 36 | challenge this is not | | | | | | | 1 | 0.65% |
| 37 | global challenge this is | | | | | | | 1 | 0.65% |
| 38 | a global challenge this | | | | | | | 1 | 0.65% |
| 39 | brucellosis a global challenge | | | | | | | 1 | 0.65% |
| 40 | here brucellosis a global | | | | | | | 1 | 0.65% |